Login to Your Account



Other News To Note


Monday, January 10, 2011
Targeted Genetics Corp., of Seattle, completed acquisition of Biocontrol Ltd., of London. Targeted Genetics will issue 22,586,073 shares of common stock to Biocontrol shareholders, who will then hold about 50 percent of Targeted Genetics. As a condition prior to the acquisition, Biocontrol raised $310,000 in working capital for use by Targeted Genetics.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription